Personalized cancer treatment for pancreatic cancer patients
Profile-Related Evidence Determining Individualized Cancer Therapy in Pancreatic Cancer (PREDICT-PANC)
This study is testing if personalized cancer treatments based on tumor testing can help adults with pancreatic cancer respond better to therapy and improve their survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical College of Wisconsin Academic / other |
| Locations | 1 site (Milwaukee, Wisconsin) |
| Trial ID | NCT05914987 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the effectiveness and tolerability of personalized cancer therapies based on molecular tumor profiling in adults with pancreatic cancer. It will analyze patient medical records, both retrospectively and prospectively, to assess how well molecular testing predicts responses to targeted therapies. Key parameters such as tumor response, time to treatment failure, patient survival, and toxicity will be evaluated to understand the potential benefits of individualized treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a pathologically confirmed diagnosis of pancreatic cancer.
Not a fit: Patients with primary cancer diagnoses other than pancreatic cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective and tailored treatment options for patients with pancreatic cancer.
How similar studies have performed: Other studies have shown promise in using molecular profiling for personalized cancer therapies, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Pathologically confirmed pancreatic cancer. * Ability to understand a written informed consent document and the willingness to sign it Exclusion Criteria: * Age \<18 years. * Primary cancer diagnosis other than pancreatic cancer.
Where this trial is running
Milwaukee, Wisconsin
- Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin, United States (Recruiting)
Study contacts
- Principal investigator: Mandana Kamgar, MD — Medical College of Wisconsin
- Study coordinator: Cancer Center Clinical Trials Office
- Email: cccto@mcw.edu
- Phone: 1-414-805-8900
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.